Literature DB >> 25543699

[CSF3R, ASXL1,SETBP1, JAK2 V617F and CALR mutations in chronic neutrophilic leukemia].

Yajuan Cui1, Bing Li1, Qian Jiang1, Zefeng Xu1, Tiejun Qin1, Peihong Zhang1, Yue Zhang1, Zhijian Xiao1.   

Abstract

OBJECTIVE: To observe the CSF3R, ASXL1, SETBP1, JAK2 V617F and CALR mutations in patients with chronic neutrophilic leukemia (CNL).
METHODS: Twelve suspected "CNL" patients were retrospectively reviewed according the WHO criteria (2008). CSF3R,ASXL1,SETBP1 and CALR mutations were sequenced, and JAK2 V617F was tested by allele specific (AS)-PCR.
RESULTS: 6 of 12 cases were diagnosed as CML, and all of the 6 carried. 4 of 6 patients also had ASXL1 and SETBP1 mutations and one had a CALR mutation (c.1154-1155insTTGTC). Two patients with monoclonal gammopathy with uncertain significance (MGUS) combined with CNL-like symptoms had no CSF3R, ASXL1, SETBP1, JAK2 V617F or CALR mutation. The same results were also seen in other 4 cases with secondary neutrophilic leukocytosis.
CONCLUSION: CSF3R, ASXL1 and SETBP1 mutations differential diagnosis of CNL, and should be included in the diagnostic protocol so as to improve diagnostic accuracy for CNL.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25543699     DOI: 10.3760/cma.j.issn.0253-2727.2014.12.005

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN: 0253-2727


  3 in total

1.  Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.

Authors:  Li-Hong Shou; Dan Cao; Xiao-Hui Dong; Qiu Fang; Ying Wu; Yan Zhang; Ju-Ping Fei; Bao-Lian Xu
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

2.  [The clinical characteristics, gene mutations and prognosis of chronic neutrophilic leukemia].

Authors:  Y J Cui; Q Jiang; J Q Liu; B Li; Z F Xu; T J Qin; Y Zhang; W Y Cai; H L Zhang; L W Fang; L J Pan; N B Hu; S Q Qu; Z J Xiao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-01-14

3.  Analysis of genetic variants in myeloproliferative neoplasms using a 22-gene next-generation sequencing panel.

Authors:  Jaymi Tan; Yock Ping Chow; Norziha Zainul Abidin; Kian Meng Chang; Veena Selvaratnam; Nor Rafeah Tumian; Yang Ming Poh; Abhi Veerakumarasivam; Michael Arthur Laffan; Chieh Lee Wong
Journal:  BMC Med Genomics       Date:  2022-01-15       Impact factor: 3.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.